Free Articles
Free to read — no membership required.
I Have APOE4. What Do I Do Now?
Written for someone who has just received an APOE4 result and does not yet know what it means — what the genotype does, what it does not, and the actions that have evidence behind them.
What APOE4 Means: A Practical Guide for Patients
What carrying one or two copies of APOE ε4 means for your brain, your risk, and the decisions in front of you — in plain language.
APOE 2, 3, and 4: What the Three Versions of This Gene Actually Do
Three versions of one gene, separated by two amino acids — and why that small difference sends Alzheimer’s risk in three different directions.
APOE ε4 Risk Is Not the Same in Every Population
The widely quoted risk figures come almost entirely from people of European ancestry. How much the numbers change elsewhere, and the haplotype explanation for why.
Supplements and APOE ε4: DHA, Vitamins, and What the Evidence Really Shows
No supplement has been proven to prevent or slow Alzheimer’s disease because you carry ε4. What to take, what to discuss with your doctor, and what to skip — DHA, vitamin E, B12, and more.
APOE ε4 or ApoE4? A Clinician’s Guide to Correct Nomenclature
Gene, allele, protein isoform, and search term are four different things. A short reference for using each correctly in writing and in clinic.
Stem Cells, Exosomes, and Peptides for Alzheimer’s Disease: What the Evidence Shows
A clinical review of regenerative therapies marketed to APOE ε4 carriers — what randomized evidence actually supports, and where it doesn’t.
The End of Alzheimer’s Program: A Neurologist’s Review
A board-certified neurologist and APOE ε4 carrier reviews Dale Bredesen’s bestselling protocol — what the evidence supports, and where it overclaims.
No More Sleepless Nights: A Neurologist’s Review
A physician’s review of a popular sleep program, and what the evidence actually says about sleep and APOE ε4 risk.
Why Some Scientists Question the Amyloid Hypothesis
Why the leading theory of Alzheimer’s disease is being challenged — and why it doesn’t change what APOE ε4 carriers should do.
Alzheimer’s Treatments and Emerging Therapies: A Guide for APOE ε4 Carriers
Current FDA-approved therapies, what’s in clinical trials, and what APOE ε4 status means for treatment candidacy.
Navigating Pre-Death Grief: Managing the Emotional Toll of Dementia Caregiving
The grief that begins long before the death does — why it is so often unrecognized, and what helps caregivers carry it.
Key Considerations After a Dementia Diagnosis in APOE ε4 Carriers
The decisions that matter most in the first months after a diagnosis, and the ones that can safely wait.
Who Helps After a Dementia Diagnosis? Building Your Care Team
Who belongs on the care team after a dementia diagnosis — and how to actually find a geriatric psychiatrist or social worker.
Intermittent Fasting: A Patient Guide
What intermittent fasting has been shown to do for brain aging, what remains mechanistic only, and who should not attempt it.
APOE ε4 Carriers and Meat
Dietary meat intake and cognitive outcomes in APOE ε4 carriers, and what the observational data can and cannot establish.
Member-Only Articles
Full clinical reviews and evidence tables. Become a member to unlock the complete library.
-
Talking About Lecanemab and Donanemab: A Plain-Language Guide for Patients, Caregivers, and Primary Care Doctors
Lecanemab slowed 18-month decline by about 27% and donanemab by about 29% on the CDR-SB, roughly 5 months…
-
Alcohol, Binge Drinking, Ultra-Processed Food, and Cannabis: Where the Dementia Evidence Draws the Line for APOE ε4 Carriers
Evidence Review · Diet, Alcohol, and Cannabis · Dementia Risk Alcohol, Binge Drinking, Ultra-Processed Food, and Cannabis: Where…
-
Learning and Practice in Alzheimer’s Dementia: What Skill Science Offers Patients and Caregivers
In the GREAT trial of 475 people with mild to moderate dementia, goal-oriented cognitive rehabilitation produced large gains…
-
Beyond Amyloid: Why Tau Is the Next Frontier in Alzheimer’s Therapy
Anti-amyloid antibodies slow Alzheimer’s disease by roughly a quarter to a third over 18 months; they do not…
-
Lp(a) and ApoB: Two Cholesterol Tests Your Standard Panel Misses
Your standard cholesterol panel leaves out two useful numbers. ApoB counts the particles that carry cholesterol into your…
-
Lp(a) and ApoB: Two Different Questions About Atherogenic Risk, and Where APOE ε4 Fits
UK Biobank data show apoB is the only lipid measure that stays associated with MI when modeled alongside…
-
Can Brain Stimulation Slow Memory Loss? Ultrasound, Magnetic Stimulation, and What They Mean for APOE ε4 Carriers
Transcranial ultrasound and magnetic stimulation are being promoted for memory loss. A neurologist reviews the trials, safety, where…
-
How Common Is Alzheimer’s—and What Do the Numbers Mean If You Carry APOE4?
About 1 in 20 Americans aged 65–74 has clinical Alzheimer’s disease, and about 1 in 3 over 85.…
-
Your p-tau217 Blood Test and APOE4: What the New Evidence Means
A new pooled analysis in Lancet Neurology shows that the same plasma p-tau217 level signals faster progression to…
